233
Views
0
CrossRef citations to date
0
Altmetric
Case reports

Myocarditis Following Inactivated SARS-CoV-2 Vaccine (Vero Cell) in an Adult Female in Vietnam: A Case Report

, , , ORCID Icon, & ORCID Icon
Pages 551-559 | Received 10 May 2023, Accepted 03 Sep 2023, Published online: 15 Sep 2023

References

  • Bozkurt B, Kamat I, Hotez PJ. Myocarditis with COVID-19 mRNA vaccines. Circulation. 2021;144(6):471–484. doi:10.1161/CIRCULATIONAHA.121.056135
  • Barouch DH. Covid-19 vaccines — immunity, variants, boosters. N Engl J Med. 2022;387:1011–1020. doi:10.1056/NEJMra2206573
  • Das BB, Moskowitz WB, Taylor MB, Palmer A. Myocarditis and pericarditis following mRNA COVID-19 vaccination: what do we know so far? Children. 2021;8(7):607. doi:10.3390/children8070607
  • Patone M, Mei XW, Handunnetthi L, et al. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat Med. 2022;28(2):410–422. doi:10.1038/s41591-021-01630-0
  • Ferreira VM, Schulz-Menger J, Holmvang G, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol. 2018;72(24):3158–3176. doi:10.1016/j.jacc.2018.09.072
  • Reuters. Israel examining heart inflammation cases in people who received Pfizer COVID shot; 2021.
  • Kim HW, Jenista ER, Wendell DC, et al. Patients with acute myocarditis following mRNA COVID-19 Vaccination. JAMA Cardiol. 2021;6(10):1196–1201. doi:10.1001/jamacardio.2021.2828
  • Lai FTT, Li X, Peng K, et al. Carditis After COVID-19 vaccination with a messenger RNA vaccine and an inactivated virus vaccine: a case-control study. Ann Intern Med. 2022;175(3):362–370. doi:10.7326/M21-3700
  • Hromić-Jahjefendić A, Sezer A, Aljabali AAA, et al. COVID-19 vaccines and myocarditis: an overview of current evidence. Biomedicines. 2023;11(5):1469. doi:10.3390/biomedicines11051469
  • Caforio ALP, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on myocardial and pericardial diseases. Eur Heart J. 2013;34(33):2636–2648. doi:10.1093/eurheartj/eht210
  • Heidecker B, Dagan N, Balicer R, et al. Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC working group on myocardial and pericardial diseases. Eur J Heart Fail. 2022;24(11):2000–2018. doi:10.1002/ejhf.2669
  • Cui G, Li R, Zhao C, Wang DW. Case Report: COVID-19 vaccination associated fulminant myocarditis. Front Cardiovasc Med. 2022;2022:8.